Cargando…

Intranasal administration of a recombinant RBD vaccine induces long-term immunity against Omicron-included SARS-CoV-2 variants

The outbreak of coronavirus disease 2019 (COVID-19) has posed great threats to global health and economy. Several effective vaccines are available now, but additional booster immunization is required to retain or increase the immune responses owing to waning immunity and the emergency of new variant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lei, Hong, Alu, Aqu, Yang, Jingyun, Ren, Wenyan, He, Cai, Lan, Tianxia, He, Xuemei, Yang, Li, Li, Jiong, Wang, Zhenling, Song, Xiangrong, Wang, Wei, Lu, Guangwen, Wei, Xiawei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112270/ https://www.ncbi.nlm.nih.gov/pubmed/35581200 http://dx.doi.org/10.1038/s41392-022-01002-1

Ejemplares similares

Cationic crosslinked carbon dots-adjuvanted intranasal vaccine induces protective immunity against Omicron-included SARS-CoV-2 variants
por: Lei, Hong, et al.
Publicado: (2023)

Cationic nanocarriers as potent adjuvants for recombinant S-RBD vaccine of SARS-CoV-2
por: Lei, Hong, et al.
Publicado: (2020)

A recombinant spike‐XBB.1.5 protein vaccine induces broad‐spectrum immune responses against XBB.1.5‐included Omicron variants of SARS‐CoV‐2
por: He, Cai, et al.
Publicado: (2023)

Low levels of neutralizing antibodies against XBB Omicron subvariants after BA.5 infection
por: Yang, Jingyun, et al.
Publicado: (2023)

Heterologous vaccination with subunit protein vaccine induces a superior neutralizing capacity against BA.4/5‐included SARS‐CoV‐2 variants than homologous vaccination of mRNA vaccine
por: Peng, Dandan, et al.
Publicado: (2023)

Intranasal COVID-19 vaccines: From bench to bed
por: Alu, Aqu, et al.
Publicado: (2022)

Spike protein of SARS‐CoV‐2 Omicron (B.1.1.529) variant has a reduced ability to induce the immune response
por: He, Cai, et al.
Publicado: (2022)

Trimeric protein vaccine based on Beta variant elicits robust immune response against BA.4/5-included SARS-CoV-2 Omicron variants
por: He, Cai, et al.
Publicado: (2023)

A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS‐CoV‐2 variants and wild‐type of the virus
por: He, Cai, et al.
Publicado: (2021)

A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant
por: He, Cai, et al.
Publicado: (2022)

SARS‐CoV‐2 Omicron variant: Characteristics and prevention
por: He, Xuemei, et al.
Publicado: (2021)

cGAS-STING pathway in cancer biotherapy
por: Wang, Yang, et al.
Publicado: (2020)

The modulatory effect of high salt on immune cells and related diseases
por: Li, Xian, et al.
Publicado: (2022)

SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development
por: Ao, Danyi, et al.
Publicado: (2022)

Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19
por: Ni, Yanghong, et al.
Publicado: (2021)

S19W, T27W, and N330Y mutations in ACE2 enhance SARS-CoV-2 S-RBD binding toward both wild-type and antibody-resistant viruses and its molecular basis
por: Ye, Fei, et al.
Publicado: (2021)

BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies
por: Alu, Aqu, et al.
Publicado: (2022)

The role of lysosome in regulated necrosis
por: Alu, Aqu, et al.
Publicado: (2020)

Biomaterial-assisted biotherapy: A brief review of biomaterials used in drug delivery, vaccine development, gene therapy, and stem cell therapy
por: Han, Xuejiao, et al.
Publicado: (2022)

Characterization of SARS-CoV-2 Omicron spike RBD reveals significantly decreased stability, severe evasion of neutralizing-antibody recognition but unaffected engagement by decoy ACE2 modified for enhanced RBD binding
por: Lin, Sheng, et al.
Publicado: (2022)

Antitumor and Radiosensitization Effects of a CXCR2 Inhibitor in Nasopharyngeal Carcinoma
por: Liu, Xiaobei, et al.
Publicado: (2021)

Tripterin liposome relieves severe acute respiratory syndrome as a potent COVID-19 treatment
por: Que, Haiying, et al.
Publicado: (2022)

Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant
por: Zang, Jinkai, et al.
Publicado: (2022)

The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants
por: Ao, Danyi, et al.
Publicado: (2023)

Histones released by NETosis enhance the infectivity of SARS-CoV-2 by bridging the spike protein subunit 2 and sialic acid on host cells
por: Hong, Weiqi, et al.
Publicado: (2022)

Structural insights into the SARS-CoV-2 Omicron RBD-ACE2 interaction
por: Lan, Jun, et al.
Publicado: (2022)

Broad protective RBD heterotrimer vaccines neutralize SARS-CoV-2 including Omicron sub-variants XBB/BQ.1.1/BF.7
por: Zhang, Yanfang, et al.
Publicado: (2023)

Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants
por: Mäkelä, Anna R., et al.
Publicado: (2023)

Scanning the RBD-ACE2 molecular interactions in Omicron variant
por: Rath, Soumya Lipsa, et al.
Publicado: (2022)

TFAM deficiency in dendritic cells leads to mitochondrial dysfunction and enhanced antitumor immunity through cGAS-STING pathway
por: Lu, Tianqi, et al.
Publicado: (2023)

Omicron variant: a booster depending on infection histories
por: Wang, Jiayu, et al.
Publicado: (2023)

Effect of Delta and Omicron Mutations on the RBD-SD1 Domain of the Spike Protein in SARS-CoV-2 and the Omicron Mutations on RBD-ACE2 Interface Complex
por: Ching, Wai-Yim, et al.
Publicado: (2022)

Inhibition of 15-PDGH: a strategy to rejuvenate aged muscles?
por: Lan, Tianxia, et al.
Publicado: (2021)

Inflammatory Cytokines in Cancer: Comprehensive Understanding and Clinical Progress in Gene Therapy
por: Lan, Tianxia, et al.
Publicado: (2021)

An updated RBD-Fc fusion vaccine booster increases neutralization of SARS-CoV-2 Omicron variants
por: Luo, Deyan, et al.
Publicado: (2022)

Intranasal Boosting with Spike Fc-RBD of Wild-Type SARS-CoV-2 Induces Neutralizing Antibodies against Omicron Subvariants and Reduces Viral Load in the Nasal Turbinate of Mice
por: Cai, Jian-Piao, et al.
Publicado: (2023)

Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
por: Cao, Yunlong, et al.
Publicado: (2022)

Intranasal administration of a recombinant RBD vaccine induced protective immunity against SARS-CoV-2 in mouse
por: Du, Yingying, et al.
Publicado: (2021)

Antigenicity comparison of SARS‐CoV‐2 Omicron sublineages with other variants contained multiple mutations in RBD
por: Li, Qianqian, et al.
Publicado: (2022)

Targeted therapy for head and neck cancer: signaling pathways and clinical studies
por: Li, Qingfang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cldmd0d8jnc5ppfu7fsp7lfjtd